• Abbott Laboratories average debt/equity ratio for 2024 was 0.31, a 18.42% decline from 2023.
• Abbott Laboratories average debt/equity ratio for 2023 was 0.38, a 13.64% decline from 2022.
• Abbott Laboratories average debt/equity ratio for 2022 was 0.44, a 13.73% decline from 2021.

Debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity.